Medicine and Dentistry
Chemotherapy
100%
Cetuximab
100%
Radiation Therapy
50%
Head and Neck Cancer
50%
Tumor Progression
50%
Epidermal Growth Factor Receptor
50%
Therapeutic Procedure
50%
Radiation
50%
Monoclonal Antibody
25%
Ligand
25%
Malignant Neoplasm
25%
Cell Membrane
25%
Overall Survival
25%
Tumor Cell
25%
Survival
25%
Head
25%
Neck
25%
Biochemistry, Genetics and Molecular Biology
Cetuximab
100%
Clinical Trial
100%
Epidermal Growth Factor Receptor
50%
Dimerization
50%
Monoclonal Antibody
25%
Cell Membrane
25%
Overall Survival
25%
Radiation
25%
Survival
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cetuximab
100%
Head and Neck Cancer
50%
Tumor Growth
50%
Epidermal Growth Factor Receptor
50%
Ligand
25%
Squamous Cell Carcinoma
25%
Overall Survival
25%
Monoclonal Antibody
25%
Malignant Neoplasm
25%
Survival
25%
Neuroscience
Cetuximab
100%
Radiation Therapy
50%
Chemotherapy
50%
Cell Membrane
25%
Ligand
25%
Chemistry
Dimerization
50%
Epidermal Growth Factor
50%
Monoclonals
25%
Ligand
25%